Inhibitors of pancreatic lipase: State of the art and clinical perspectives

EXCLI Journal

Volumn 13, Issue , 2014, Pages 897-921

  Lunagariya, Nitin A ^a   Patel, Neeraj K ^a   Jagtap, Sneha C ^a   Bhutani, Kamlesh K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Clinical perspectives; Lipid metabolism; Natural products; Obesity; Orlistat; Pancreatic lipase

Indexed keywords

2 METHYLGLYCEROL; 2 OXO AMIDE TRIACYLGLYCEROL; ALKALOID DERIVATIVE; AMFEPRAMONE; CAROTENOID; CAULERPENYNE; CETILISTAT; DELTA POLYLYSINE; DIHYDROXY BENZOMACROLIDE; EBELACTONE A; EBELACTONE B; ESTERASE INHIBITOR; GLYCEROL; GLYCOSIDE; GT 389255; LORCASERIN; METHAMPHETAMINE; PHENDIMETRAZINE; PHENTERMINE; POLYLYSINE; POLYPHENOL DERIVATIVE; POLYSACCHARIDE; RIMONABANT; SAPONIN DERIVATIVE; SIBUTRAMINE; TERPENE DERIVATIVE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALILACTONE;

DRUG BINDING; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; FOOD INTAKE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID ABSORPTION; LIPID METABOLISM; LIPOPHILICITY; MICROORGANISM; NONHUMAN; OBESITY; PHYTOCHEMISTRY; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 84907660761     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Aronne LJ. Classification of obesity and assessment of obesity-related health risks. Obesity 2002;10:105S-15S.
2. Barsh GS, Farooqi IS, O’Rahilly S. Genetics of bodyweight regulation. Nature 2000;404:644-51.
3. Birari RB, Gupta S, Gopi Mohan C, Bhutani KK. Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies. Phytomedicine 2011;18:795-801.
4. Bitou N, Ninomiya M, Tsujita T, Okuda H. Screening of lipase inhibitors from marine algae. Lipids 1999;34:441-5.
5. Cairns E. Obesity: the fat lady sings? Drug Discov Today 2005;10:305-7.
6. Chiou A, Markidis T, Constantinou-Kokotou V, Verger R, Kokotos G. Synthesis and study of a lipophilic alpha-keto amide inhibitor of pancreatic lipase. Org Lett 2000;2:347-50.
7. Chiou A, Verger R, Kokotos G. Synthetic routes and lipase-inhibiting activity of long-chain alpha-keto amides. Lipids 2001;36:535-42.
8. Constantinou-Kokotou V, Magrioti V, Verger R. Sterically hindered triacylglycerol analogues as potent inhibitors of human digestive lipases. Chemistry 2004;10:1133-40.
9. Elangbam CS. Current strategies in the development of anti-obesity drugs and their safety concerns. Vet Pathol 2009;46:10-24.
10. Eom SH, Lee MS, Lee EW, Kim YM, Kim TH. Pancreatic lipase inhibitory activity of phlorotannins isolated from Eisenia bicyclis. Phytother Res 2013;27: 148-51.
11. Gonzalez-Castejon M, Rodriguez-Casado A. Dietary phytochemicals and their potential effects on obesity: a review. Pharmacol Res 2011;64:438-55.
12. Gout B, Bourges C, Paineau-Dubreuil S. Satiereal, a Crocus sativus L. extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res 2010;30:305-13.
13. Guo Y, Wang H, Gong J, Zhang X, Jiang C. Preparation of benzomacrolides as pancreatic lipase inhibitors. PCT Int Appl (2011), WO 2011072623 A1 20110623.
14. Habtemariam S. Antihyperlipidemic components of Cassia auriculata aerial parts: identification through in vitro studies. Phytother Res 2013;27:152-5.
15. Han LK, Takaku T, Li J, Kimura Y, Okuda H. Antiobesity action of oolong tea. Int J Obes Relat Metab Disord 1999;23:98-105.
16. Han LK, Xu BJ, Kimura Y, Zheng Yn, Okuda H. Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity. J Nutr 2000;130:2760-4.
17. Han LK, Kimura Y, Kawashima M, Takaku T, Taniyama T, Hayashi T et al. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int J Obes Relat Metab Disord 2001;25:1459-64.
18. Han LK, Zheng YN, Xu BJ, Okuda H, Kimura Y. Saponins from Platycodi radix ameliorate high fat diet-induced obesity in mice. J Nutr 2002;132:2241-5.
19. Han LK, Zheng YN, Yoshikawa M, Okuda H, Kimura Y. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement Altern Med 2005;5:9-18.
20. Han L, Li W, Narimatsu S, Liu L, Fu H, Okuda H et al. Inhibitory effects of compounds isolated from fruit of Juglans mandshurica on pancreatic lipase. J Nat Med 2007;61:184-6.
21. Hatano T, Yamashita A, Hashimoto T, Ito H, Kubo N, Yoshiyama M et al. Flavan dimers with lipase inhibitory activity from Cassia nomame. Phytochemistry 1997;46:893-900.
22. Hochuli E, Kupfer E, Maurer R, Meister W, Mercadal Y, Schmidt K. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. II. Chemistry and structure elucidation. J Antibiot (Tokyo) 1987;40:1086-91.
23. Hopmann C, Kurz M, Mueller G, Toti L. Percyquinnin, a process for its production and its use as a pharmaceutical. US Patent no. US6596518 B2 (2003).
24. Jang DS, Lee GY, Kim J, Lee YM, Kim JM, Kim YS et al. A new pancreatic lipase inhibitor isolated from the roots of Actinidia arguta. Arch Pharm Res 2008;31:666-70.
25. Kaila B, Raman M. Obesity: a review of pathogenesis and management strategies. Can J Gastroenterol 2008;22:61-8.
26. Kato E, Yama M, Nakagomi R, Shibata T, Hosokawa K, Kawabata J. Substrate-like water soluble lipase inhibitors from Filipendula kamtschatica. Bioorg Med Chem Lett 2012;22:6410-2.
27. Kawaguchi K, Mizuno T, Aida K, Uchino K. Hesperidin as an inhibitor of lipases from porcine pancreas and Pseudomonas. Biosci Biotechnol Biochem 1997;61:102-4.
28. Kimura H, Ogawa S, Jisaka M, Kimura Y, Katsube T, Yokota K. Identification of novel saponins from edible seeds of Japanese horse chestnut (Aesculus turbinata Blume) after treatment with wooden ashes and their nutraceutical activity. J Pharm Biomed Anal 2006;41:1657-65.
29. Kitahara M, Asano M, Naganawa H, Maeda K, Hamada M, Aoyagi T et al. Valilactone, an inhibitor of esterase, produced by actinomycetes. J Antibiot (Tokyo) 1987;40:1647-50.
30. Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S et al. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients. Int J Obes (Lond) 2007;31:494-9.
31. Kotsovolou S, Chiou A, Verger R, Kokotos G. Bis-2-oxo amide triacylglycerol analogues: a novel class of potent human gastric lipase inhibitors. J Org Chem 2001;66:962-7.
32. Kumar D, Karmase A, Jagtap S, Shekhar R, Bhutani KK. Pancreatic lipase inhibitory activity of cassiamin A, a bianthraquinone from Cassia siamea. Nat Prod Commun 2013;8:195-8.
33. Kumar S, Alagawadi KR. Anti-obesity effects of galangin, a pancreatic lipase inhibitor in cafeteria diet fed female rats. Pharm Biol 2013;51:607-13.
34. Kurihara H, Asami S, Shibata H, Fukami H, Tanaka T. Hypolipemic effect of Cyclocarya paliurus (Batal) iljinskaja in lipid-loaded mice. Biol Pharm Bull 2003;26:383-5.
35. Kwon CS, Sohn HY, Kim SH, Kim JH, Son KH, Lee JS et al. Anti-obesity effect of Dioscorea nipponica Makino with lipase-inhibitory activity in rodents. Biosci Biotechnol Biochem 2003;67:1451-6.
36. Lairon D, Lafont H, Vigne JL, Nalbone G, Leonardi J, Hauton JC. Effects of dietary fibers and cholestyramine on the activity of pancreatic lipase in vitro. Am J Clin Nutr 1985;42:629-38.
37. Lam DD, Przydzial MJ, Ridley SH, Yeo GS, Rochford JJ, O’Rahilly S et al. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 2008;149:1323-8.
38. Lee EM, Lee SS, Chung BY, Cho JY, Lee IC, Ahn SR et al. Pancreatic lipase inhibition by C-glycosidic flavones isolated from Eremochloa ophiuroides. Molecules 2010;15:8251-9.
39. Lee IA, Lee JH, Baek NI, Kim DH. Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin. Biol Pharm Bull 2005;28:2106-10.
40. Li F, Li W, Fu H, Zhang Q, Koike K. Pancreatic lipase-inhibiting triterpenoid saponins from fruits of Acanthopanax senticosus. Chem Pharm Bull (Tokyo) 2007;55:1087-9.
41. Liu DZ, Wang F, Liao TG, Tang JG, Steglich W, Zhu HJ et al. Vibralactone: a lipase inhibitor with an unusual fused β-lactone produced by cultures of the basidiomycete Boreostereum vibrans. Org Lett 2006;8: 5749-52.
42. Liu W, Zheng Y, Han L, Wang H, Saito M, Ling M et al. Saponins (Ginsenosides) from stems and leaves of Panax quinquefolium prevented high-fat diet-induced obesity in mice. Phytomedicine 2008;15:1140-5.
43. Magrioti V, Verger R, Constantinou-Kokotou V. Triacylglycerols based on 2-(N-tert-butoxycarbonylamino) oleic acid are potent inhibitors of pancreatic lipase. J Med Chem 2004;47:288-91.
44. Matsumoto M, Hosokawa M, Matsukawa N, Hagio M, Shinoki A, Nishimukai M et al. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph ductcannulated rats. Eur J Nutr 2010;49:243-9.
45. McBride R. "Genzyme-spinout Peptimmune files for chapter 7 liquidation". Boston, MA:Xconomy, 2011. link:http://www.xconomy.com/boston/2011/03/23/ge nzyme-spinout-peptimmune-files-for-chapter-7-liquidation/, Accessed on 22/05/2014.
46. Moreno DA, Ilic N, Poulev A, Brasaemle DL, Fried SK, Raskin I. Inhibitory effects of grape seed extract on lipases. Nutrition 2003;19:876-9.
47. Moreno DA, Ilic N, Poulev A, Raskin I. Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters. Life Sci 2006a;78: 2797-803.
48. Moreno DA, Ripoll C, Ilic N, Poulev A, Aubin C, Raskin I. Inhibition of lipid metabolic enzymes using Mangifera indica extracts. J Food Agric Environ 2006b;4:21-6.
49. Mukherjee M. Human digestive and metabolic lipases-a brief review. J Mol Catal B: Enzym 2003;22:369-76.
50. Mutoh M, Nakada N, Matsukuma S, Ohshima S, Yoshinari K, Watanabe J et al. Panclicins, novel pancreatic lipase inhibitors. I. Taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) 1994;47:1369-75.
51. Nakai M, Fukui Y, Asami S, Toyoda-Ono Y, Iwashita T, Shibata H et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem 2005;53:4593-8.
52. Ninomiya K, Matsuda H, Shimoda H, Nishida N, Kasajima N, Yoshino T et al. Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg Med Chem Lett 2004;14:1943-6.
53. Ono Y, Hattori E, Fukaya Y, Imai S, Ohizumi Y. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J Ethnopharmacol 2006;106:238-44.
54. Roy DM, Schneeman BO. Effect of soy protein, casein and trypsin inhibitor on cholesterol, bile acids and pancreatic enzymes in mice. J Nutr 1981;111: 878-85.
55. Shi Y, Burn P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov 2004;3:695-710.
56. Shin JE, Joo Han M, Kim DH. 3-methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase. Biol Pharm Bull 2003;26:854-7.
57. Stull AJ, Cash KC, Johnson WD, Champagne CM, Cefalu WT. Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J Nutr 2010;140:1764-8.
58. Sugimoto S, Nakamura S, Yamamoto S, Yamashita C, Oda Y, Matsuda H et al. Brazilian natural medicines. III. Structures of triterpene oligoglycosides and lipase inhibitors from mate, leaves of Ilex paraguariensis. Chem Pharm Bull 2009;57:257-61.
59. Sugiyama H, Akazome Y, Shoji T, Yamaguchi A, Yasue M, Kanda T et al. Oligomeric procyanidins in apple polyphenol are main active components for inhibition of pancreatic lipase and triglyceride absorption. J Agric Food Chem 2007;55:4604-9.
60. Sumiyoshi M, Kimura Y. Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J Pharm Pharmacol 2006;58: 201-7.
61. Takeda Pharmaceutical Company Limited, Osaka, Japan. A phase 3, multicentre, randomized, stratified, placebo-controlled, double-blind, parallel-group study to investigate the efficacy and safety of ATL-962 in obese patients with Type 2 diabetes and dyslipidemia. Protocol No. ATL-962/CCT-002.
62. Takeda Pharmaceutical Company Limited, Osaka, Japan. A phase 3, open-label study to investigate the efficacy and safety of ATL-962 in obese patients with Type 2 diabetes and dyslipidemia. Protocol No. ATL-962/OCT-001.
63. Takeda Pharmaceutical Company Limited, Osaka, Japan. A phase 3, open-label, multicenter study to evaluate the safety and efficacy of long-term treatment with ATL-962 in obese patients with Type 2 diabetes mellitus and dyslipidemia. Protocol No. ATL-962/OCT-002.
64. Tokdar P, Ranadive P, Mascarenhas M, Patil S, George S. (E)-4-aminostyryl acetate a novel pancreatic lipase inhibitor produced by a Streptomyces sp. MTCC 5219. Int J Chem Eng Appl 2011;2:135-8.
65. Tomoda H, Namatame I, Omura S. Microbial metabolites with inhibitory activity against lipid metabolism. Proc Jpn Acad Ser B Phys Biol Sci 2002;78:217-40.
66. Tsujita T, Matsuura Y, Okuda H. Studies on the inhibition of pancreatic and carboxylester lipases by protamine. J Lipid Res 1996;37:1481-7.
67. Tsujita T, Takaichi H, Takaku T, Aoyama S, Hiraki J. Antiobesity action of ε-polylysine, a potent inhibitor of pancreatic lipase. J Lipid Res 2006;47:1852-8.
68. Umezawa H, Aoyagi T, Hazato T, Uotani K, Kojima F, Hamada M et al. Esterastin, an inhibitor of esterase, produced by actinomycetes. J Antibiot (Tokyo) 1978; 31:639-41.
69. Umezawa H, Aoyagi T, Uotani K, Hamada M, Takeuchi T, Takahashi S. Ebelactone, an inhibitor of esterase, produced by actinomycetes. J Antibiot (Tokyo) 1980;33:1594-6.
70. Weibel EK, Hadvary P, Hochuli E, Kupfer E, Lengsfeld H. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. J Antibiot (Tokyo) 1987;40:1081-5.
71. WHO. Obesity and overweight. Fact sheet No 311, Reviewed May 2014. http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed on 1st June, 2014.
72. Wikiera A, Mika M, Zyla K. Methylxanthine drugs are human pancreatic lipase inhibitors. Pol J Food Nutr Sci 2012;62:109-13.
73. Won SR, Kim SK, Kim YM, Lee PH, Ryu JH, Kim JW et al. Licochalcone A: a lipase inhibitor from the roots of Glycyrrhiza uralensis. Food Res Int 2007;40: 1046-50.
74. Wu X, He W, Zhang H, Li Y, Liu Z, He Z. Acteoside: a lipase inhibitor from the Chinese tea Ligustrum purpurascens kudingcha. Food Chem 2014;142:306-10.
75. Xu BJ, Han LK, Zheng YN, Lee JH, Sung CK. In vitro inhibitory effect of triterpenoidal saponins from Platycodi Radix on pancreatic lipase. Arch Pharm Res 2005;28:180-5.
76. Yamada Y, Kato T, Ogino H, Ashina S, Kato K. Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats. Horm Metab Res 2008;40:539-43.
77. Yamamoto M, Shimura S, Itoh Y, Ohsaka T, Egawa M, Inoue S. Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. Int J Obes Relat Metab Disord 2000;24:758-64.
78. Yoshikawa M, Shimoda H, Nishida N, Takada M, Matsuda H. Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats. J Nutr 2002; 132:1819-24.
79. Yoshikawa M, Sugimoto S, Kato Y, Nakamura S, Wang T, Yamashita C et al. Acylated oleanane-type triterpene saponins with acceleration of gastrointestinal transit and inhibitory effect on pancreatic lipase from flower buds of Chinese tea plant (Camellia sinensis). Chem Biodivers 2009;6:903-15.
80. Yoshinari K, Aoki M, Ohtsuka T, Nakayama N, Itezono Y, Mutoh M et al. Panclicins, novel pancreatic lipase inhibitors. II. Structural elucidation. J Antibiot (Tokyo) 1994;47:1376-84.
81. Yoshizumi K, Hirano K, Ando H, Hirai Y, Ida Y, Tsuji T et al. Lupane type saponins from leaves of Acanthopanax sessiliflorus and their inhibitory activity on pancreatic lipase. J Agric Food Chem 2006;54: 335-41.
82. Zhao HL, Kim YS. Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1,2-diglyceride-based colorimetric assay. Arch Pharm Res 2004;27:968-72.
83. Zhao HL, Sim JS, Shim SH, Ha YW, Kang SS, Kim YS. Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction. Int J Obes (Lond) 2005;29:983-90.
84. Zheng Q, Koike K, Han LK, Okuda H, Nikaido T. New biologically active triterpenoid saponins from Scabiosa tschiliensis. J Nat Prod 2004;67:604-13.
85. Zheng Q, Li W, Han L, Koike K. Pancreatic lipaseinhibiting triterpenoid saponins from Gypsophila oldhamiana. Chem Pharm Bull (Tokyo) 2007;55:646-50.